Carregant...

Effect of Maraviroc on HIV Disease Progression-Related Biomarkers

The potential effect of blocking the CCR5 receptor on HIV disease progression biomarkers is not well understood. We showed that an 8-day maraviroc (MVC) monotherapy clinical test (MCT) can be used in selecting patients to receive MVC-containing combined antiretroviral therapy (cART). Using this MCT...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Romero-Sánchez, M. Concepción, Machmach, Kawthar, Gonzalez-Serna, Alejandro, Genebat, Miguel, Pulido, Ildefonso, García-García, María, Álvarez-Ríos, Ana Isabel, Ferrando-Martinez, Sara, Ruiz-Mateos, Ezequiel, Leal, Manuel
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486555/
https://ncbi.nlm.nih.gov/pubmed/22948867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01406-12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!